Kristina Althoff
German Cancer Research Center(DE)University of Duisburg-Essen(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Neuroblastoma Research and Treatments, Pancreatic and Hepatic Oncology Research, Ubiquitin and proteasome pathways, CAR-T cell therapy research
Most-Cited Works
- → Mutational dynamics between primary and relapse neuroblastomas(2015)315 cited
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies(2014)146 cited
- → BET bromodomain protein inhibition is a therapeutic option for medulloblastoma(2013)142 cited
- → Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression(2017)141 cited
- → MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A(2013)116 cited
- → Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression(2022)88 cited
- → miR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating S urvivin(2014)83 cited
- → Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity(2019)69 cited
- → Cellular model system to dissect the isoform-selectivity of Akt inhibitors(2021)51 cited